Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

American BioOptic

American BioOptic
2006 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
6 FINANCING ROUNDS
Description

Provider of a point-of-care, personalized cancer risk assessment intended to provide immediate and accurate results to identify high-risk patients needing further evaluation. The company's accessible risk assessment system provides immediate results at the patient's point of care, right at the physician's office and requires no bowel preparation or sedation, providing medical practitioners with immediate and accurate results to identify high-risk patients needing further evaluation.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Decision/Risk Analysis
Primary Office
  • 222 West Merchandise Mart Plaza
  • Suite 1230
  • Chicago, IL 60654
  • United States

American BioOptic Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore American BioOptic‘s full profile, request access.

Request full access to PitchBook

American BioOptic Executive Team (7)

Name Title Board
Seat
Contact
Info
Eric Benson Chief Executive Officer
Erin Lavelle Chief Operating Officer
The-Quyen Nguyen Ph.D Chief Technology Officer
Hemant Roy MD Co-Founder & Clinical Expert
Michael Goldberg MD Co-Founder & Director of Clinical Relations
You’re viewing 5 of 7 executives. Get the full list »